Anti-SARS-CoV-2 Monoclonal Antibody IGM-6268

Preferred Label : Anti-SARS-CoV-2 Monoclonal Antibody IGM-6268;

NCIt definition : An engineered human immunoglobulin M (IgM) monoclonal antibody directed against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for the treatment and prevention of COVID-19. Upon intranasal administration, anti-SARS-CoV-2 IgM monoclonal antibody IGM-6268 targets and binds to SARS-CoV-2, neutralizing SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2.;

Molecule name : IGM-6268; IGM 6268;

NCI Metathesaurus CUI : CL1663293;

Details

Origin ID

C180726;

UMLS CUI

C5556591;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- IGM-6268 [MeSH Supplementary Concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients